The once-monthly RNA interference injection medication received FDA approval based on results from the phase II PHYOX2 clinical trial and phase III PHYOX3 extension study.
Researchers evaluated whether patients with atherosclerotic cardiovascular disease (ASCVD) are utilizing high-intensity statins in their routine care of the disease.
In a single-group trial, researchers assessed the safety and risks associated with interrupting endocrine therapy for women with stage I, II, or III breast cancer attempting pregnancy.
Pre-exposure prophylaxis (PrEP) adherence continues to be one of the main challenges for the elimination of HIV transmission. Researchers tested the use of an automated directly observed therapy...
In a recent study, researchers examined the effectiveness of text messaging to support the use of pre-exposure prophylaxis use in certain patient populations who are at high-risk of HIV infection.
To ensure the use of pre-exposure prophylaxis (PrEP) for HIV infection and thereby decrease the incidence of HIV, continued use of an effective dosage of preventive therapy is essential. However, research...
In a recent study, researchers compared multiple behavioral health counseling methods on HIV outcomes and risk factors for individuals living with HIV in a rural setting.
In a recent study, researchers sought to determine how the knowledge of drug-drug interactions affected hormone therapy and antiretroviral therapy adherence in transgender women with or without HIV.
